The DOI matches its Crossref record; 205 of the 209 references it cites were found in a registry or an index.
Mitochondrial defects and oxidative stress in Alzheimer disease and Parkinson disease
Open accessAbstract
Alzheimer disease (AD) and Parkinson disease (PD) are the two most common age-related neurodegenerative diseases characterized by prominent neurodegeneration in selective neural systems. Although a small fraction of AD and PD cases exhibit evidence of heritability, among which many genes have been identified, the majority are sporadic without known causes. Molecular mechanisms underlying neurodegeneration and pathogenesis of these diseases remain elusive. Convincing evidence demonstrates oxidative stress as a prominent feature in AD and PD and links oxidative stress to the development of neuronal death and neural dysfunction, which suggests a key pathogenic role for oxidative stress in both AD and PD. Notably, mitochondrial dysfunction is also a prominent feature in these diseases, which is likely to be of critical importance in the genesis and amplification of reactive oxygen species and the pathophysiology of these diseases. In this review, we focus on changes in mitochondrial DNA and mitochondrial dynamics, two aspects critical to the maintenance of mitochondrial homeostasis and function, in relationship with oxidative stress in the pathogenesis of AD and PD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“It has been proposed that ROS, which are considered markers of oxidative stress, are generated in the cytoplasm of neurons and can cause damage to key cellular components, including DNA, proteins, and lipids, leading to neuronal dysfunction and death (56, 59, 60).”
From Molecular Basis for Increased Risk for Late-onset Alzheimer Disease Due to the Naturally Occurring L28P Mutation in Apolipoprotein E4 (2014) · cites this paper as [60]
Experimental — accuracy not yet measuredIn the citing paper
“An increasing body of research indicates that ROS generation exacerbates α-synuclein misfolding in the brain, resulting in PD and other synaptic proteinopathies [37,38].”
From Neuroprotective Effects of Bifidobacterium breve CCFM1067 in MPTP-Induced Mouse Models of Parkinson’s Disease (2022) · cites this paper as [37]
In the citing paper
“In clinical studies, probiotics have been shown to lower the development of α-synuclein aggregates by lowering ROS levels, thereby improving the condition of patients with PD [37,39].”
From Neuroprotective Effects of Bifidobacterium breve CCFM1067 in MPTP-Induced Mouse Models of Parkinson’s Disease (2022) · cites this paper as [37]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Spillantini, M. G., Schmidt, M. L., Lee, V. M.-Y., Trojanowski, J. Q., Jakes, R., & Goedert, M. (1997) · Nature · doi:10.1038/42166 · Cited by 8,382
Mutation in the α-Synuclein Gene Identified in Families with Parkinson's Disease
Polymeropoulos, M. H., Lavedan, C., Leroy, E., Ide, S. E., Dehejia, A., Dutra, A., Pike, B., Root, H., Rubenstein, J., Boyer, R., et al. (1997) · Science · doi:10.1126/science.276.5321.2045 · Cited by 8,240
Mitochondrial Dysfunction and Oxidative Stress in Neurodegenerative Diseases
Lin, M. T., & Beal, M. F. (2006) · Nature · doi:10.1038/nature05292 · Cited by 6,455
Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism
Kitada, T., Asakawa, S., Hattori, N., Matsumine, H., Yamamura, Y., Minoshima, S., Yokochi, M., Mizuno, Y., & Shimizu, N. (1998) · Nature · doi:10.1038/33416 · Cited by 5,227
Hereditary Early-Onset Parkinson's Disease Caused by Mutations in PINK1
Valente, E. M., Abou-Sleiman, P. M., Caputo, V., Muqit, M. M. K., Harvey, K., Gispert, S., Ali, Z., Del Turco, D., Bentivoglio, A. R., Healy, D. G., et al. (2004) · Science · doi:10.1126/science.1096284 · Cited by 3,481
Mutations in LRRK2 Cause Autosomal-Dominant Parkinsonism with Pleomorphic Pathology
Zimprich, A. A., Biskup, S., Leitner, P., Lichtner, P., Farrer, M. J., Lincoln, S., Kachergus, J. M., Hulihan, M., Uitti, R. J., Calne, D. B., et al. (2004) · Neuron · doi:10.1016/j.neuron.2004.11.005 · Cited by 3,087
Fission and selective fusion govern mitochondrial segregation and elimination by autophagy
Twig, G., Elorza, A., Molina, A. J. A., Mohamed, H., Wikstrom, J. D., Walzer, G., Stiles, L., Haigh, S. E., Katz, S., Las, G., et al. (2008) · The EMBO Journal · doi:10.1038/sj.emboj.7601963 · Cited by 3,082
Mutations in the DJ-1 Gene Associated with Autosomal Recessive Early-Onset Parkinsonism
Bonifati, V., Rizzu, P., van Baren, M. J., Schaap, O., Breedveld, G. J., Krieger, E., Dekker, M. C. J., Squitieri, F., Ibáñez, P., Joosse, M., et al. (2003) · Science · doi:10.1126/science.1077209 · Cited by 2,854
Chen, H., Detmer, S. A., Ewald, A. J., Griffin, E. E., Fraser, S. E., & Chan, D. C. (2003) · The Journal of Cell Biology · doi:10.1083/jcb.200211046 · Cited by 2,601
Cloning of the Gene Containing Mutations that Cause PARK8-Linked Parkinson's Disease
Paisán‐Ruiz, C., Jain, S., Evans, E. W., Gilks, W. P., Simón, J., van der Brug, M., de Munaín, A. L., Aparicio, S. F., Gil, A. M., Khan, N. L., et al. (2004) · Neuron · doi:10.1016/j.neuron.2004.10.023 · Cited by 2,453
Research works printed but not linked: 1
- Bonifati, 2003, Mutations in the DJ-1 gene associated with autosomal recessive early-onset parkinsonism, Science, 299, 256, 10.1126/science.1077209 · DOI
Cited by
Sorted by citations
Items 601–700 of 720
Berezhnoy, D. S., Bokieva, S. B., Стволинский, С. Л., Федорова, Т. Н., & Inozemtsev, A. N. (2015) · Moscow University Biological Sciences Bulletin · doi:10.3103/s0096392515030037 · Cited by 3
Elusive mitochondrial connection to inflammation uncovered
Stolz, A., & Đikić, I. (2018) · Nature · doi:10.1038/d41586-018-05988-z · Cited by 3
Yuan, J., Xue, L., & Jin-Peng, R. E. N. (2022) · Journal of Neurosurgical Sciences · doi:10.23736/s0390-5616.21.05314-5 · Cited by 3
How does “Protein Corona” Affect the In vivo Efficiency of Polymeric Nanoparticles? State of Art
(2017) · BENTHAM SCIENCE PUBLISHERS eBooks · doi:10.2174/9781681084930117020011 · Cited by 4
Fullerene-Derivatives as Therapeutic Agents in Respiratory System and Neurodegenerative Disorders
Lemos, V. S., Aires, R. D., Ladeira, M. S., & Guatimosim, S. (2015) · Nanomedicine and nanotoxicology · doi:10.1007/978-3-319-25907-9_5 · Cited by 3
Singh, S. K., Tiwari, S., & Agrawal, R. (2024) · Current Bioactive Compounds · doi:10.2174/0115734072322467240816112529 · Cited by 2
Zhu, X., Wang, X., Wu, S., Guan, C., Yuan, H., Gu, W., Luo, Z., Zhang, M., Ma, S., Xu, X., et al. (2025) · Journal of Affective Disorders · doi:10.1016/j.jad.2025.04.168 · Cited by 2
Self-citationUnveiling Polyphyllin's Role in Neuroprotection: A Pharmacological Perspective
Hussain, M. S., Rana, A. J., Maqbool, M., Sulthana, N., Sultana, A., Ashique, S., Khan, Y., Ramalingam, P. S., Burle, S. S., Jakhmola, V., et al. (2025) · Pharmacological Research - Modern Chinese Medicine · doi:10.1016/j.prmcm.2025.100641 · Cited by 2
Alzheimer's disease model explains Alzheimer’s disease incidences
Chan, J. C.-Y. (2025) · Journal of Alzheimer s Disease Reports · doi:10.1177/25424823251395616 · Cited by 2
Zhang, C., Liang, X., Wang, M., Wang, K., Liu, J., Li, C., Kuang, Y., Liu, J., Zou, F., & Zhou, L. (2025) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2025.12.030 · Cited by 2
p53 regulates mitochondrial function and alpha-synuclein aggregation in Parkinson's disease
Hou, K., Chen, J., Xie, Y., Liu, T., Li, J., Meng, C., 牛冬雪, Xian, M., Li, J., Zhu, C., et al. (2026) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2026.113184 · Cited by 2
The Hepatoprotective Effects of Coenzyme Q10 Against Oxidative Stress
Farsi, F., Nezhad, P. A., & Morshedzadeh, N. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-803951-9.00023-9 · Cited by 2
Chauhan, P., Pandey, P., Khan, F., & Maqsood, R. (2023) · Endocrine Metabolic & Immune Disorders - Drug Targets · doi:10.2174/0118715303249690231006114308 · Cited by 2
Zhu, C., Tong, T., Farrell, J. J., Martin, E. R., Bush, W. S., Pericak‐Vance, M. A., Wang, L., Schellenberg, G. D., Haines, J. L., Lunetta, K. L., et al. (2024) · Journal of Alzheimer s Disease Reports · doi:10.3233/adr-230120 · Cited by 2
Identification of biomarkers of Alzheimer's disease and their characterization of immune function
Lin, M., Zhou, Y., Liang, P., Zheng, R., Du, M., Ke, X., Zhang, W., & Shang, P. (2024) · Archives of Medical Science · doi:10.5114/aoms/188721 · Cited by 2
Irfan, A., Zahoor, A. F., Boulaamane, Y., Javed, S., Hameed, H., Maurady, A., Muhammed, M. T., Ahmad, S., Al‐Mutairi, A. A., Shahzadi, I., et al. (2024) · Frontiers in Chemistry · doi:10.3389/fchem.2024.1449165 · Cited by 2
El‐Shiekh, R. A., Atwa, A. M., Elgindy, A. M., Ibrahim, K. M., Senna, M. M., Ebid, N., & Mustafa, A. M. (2024) · Chemistry & Biodiversity · doi:10.1002/cbdv.202402289 · Cited by 2
Hüttemann, M., Doan, J. W., Goustin, A. S., Sinkler, C. A., Mahapatra, G., Shay, J., Liu, J., Elbaz, H. A., Aras, S., Grossman, L. I., et al. (2014) · Cited by 2
Taylor, C. E., Abdelhadi, S. O., & Dosoretz, C. G. (2017) · Medical Hypotheses · doi:10.1016/j.mehy.2017.07.010 · Cited by 2
Chromium and Alzheimer's disease
Akhtar, A., & Sah, S. P. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-89835-5.00036-3 · Cited by 2
ANTIOXIDANT EFFECT OF FLAVONOIDS IN NEURODEGENERATIVE DISEASES
Bulboacă, A. E., Bolboaca, S. D., Stănescu, I., Sfrângeu, C. A., & Bulboacă, A. (2017) · Romanian Journal of Neurology · doi:10.37897/rjn.2017.2.2 · Cited by 1
Diabetes-related cognitive impairment and dementia
Ciudin, A., & Hernández, C. (2024) · Elsevier eBooks · doi:10.1016/b978-0-323-88426-6.00020-8 · Cited by 1
Effect of C-Phycocyanin on Isolated Mitochondria
Kuvirchenkova, A. P., Goleva, T. N., Sukhinov, D. V., Sergeeva, Y. E., & Vasilov, R. G. (2024) · Nanobiotechnology Reports · doi:10.1134/s2635167624602420 · Cited by 1
Muhammad, S. A., Aliyu, A. D., Abolaji, A. O., Jiyah, A., Bulama, I., Ibrahim, A., Abbas, A. Y., Imam, M. U., & Bilbis, L. S. (2025) · Journal of Cellular Neuroscience and Oxidative Stress · doi:10.37212/jcnos.1741523 · Cited by 1
Cytoskeletal proteins regulates Tau protein in Alzheimer’s disease
Chinnathambi, S., & Adityan, A. (2025) · Advances in protein chemistry and structural biology · doi:10.1016/bs.apcsb.2025.10.029 · Cited by 1
Offerdahl, J. E. V., & Mor, D. E. (2026) · Frontiers in Neuroscience · doi:10.3389/fnins.2026.1846384 · Cited by 1
Kermani, A., Esmaeeli, S., Vakili, R., & Hashemy, S. I. (2014) · DOAJ (DOAJ: Directory of Open Access Journals) · Cited by 1
The Consequences of Damaged Mitochondrial DNA
Zuo, L., Zhou, T., & Chuang, C. (2016) · Springer eBooks · doi:10.1007/978-3-319-42139-1_3 · Cited by 1
Suba Malani, S., & Sasi Kumar, A. (2017) · International Journal of Pharma and Bio Sciences · doi:10.22376/ijpbs.2017.8.1.p195-201 · Cited by 1
Pathophysiology of Hemorrhagic Stroke
Shi, Z. (2017) · Translational medicine research · doi:10.1007/978-981-10-5804-2_5 · Cited by 1
Alzheimer’s Disease Silent Killer of Memory: A Review on Pathological Mechanisms
Singh, S. (2019) · Alzheimer’s & Neurodegenerative Diseases · doi:10.24966/and-9608/100017 · Cited by 1
Dinámica mitocondrial en las enfermedades neurodegenerativas
Alarcón‐Aguilar, A., Maycotte, P., Cortés-Hernández, P., López‐Díazguerrero, N. E., & Königsberg, M. (2019) · Gaceta Médica de México · doi:10.24875/gmm.18004337 · Cited by 1
Sachan, N., Chauhan, B. S., & Srikrishna, S. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-90581-7.00004-9 · Cited by 1
Purinergic Signaling and its Role in the Stem Cell Differentiation
Zaib, S., Areeba, & Khan, I. A. (2023) · Mini-Reviews in Medicinal Chemistry · doi:10.2174/0113895575261206231003151416 · Cited by 1
Therapeutic Role of Nanocurcumin in Alzheimer’s and Parkinson’s Disease
Barman, D. K., & Sahoo, H. (2023) · Springer eBooks · doi:10.1007/978-981-99-7731-4_16 · Cited by 1
Radical scavenging activity of bromophenol analogs: analysis of kinetics and mechanisms
Hachemaoui, S., Ardjani, T. E. A., Brahim, H., & Alvarez-Idaboy, J. R. (2024) · Journal of Molecular Modeling · doi:10.1007/s00894-024-06010-2 · Cited by 1
Fumaria vaillantii extract protects PC12 cells against neurotoxicity induced by 6-OHDA
Javid, H., Rahimian, R., Salimi, M., Haghani-Samani, E., Farhadi, M., & Torkaman‐Boutorabi, A. (2024) · Molecular Biology Reports · doi:10.1007/s11033-024-09673-5 · Cited by 1
Involvement of Caspases in the Pathophysiology of Neurodegeneration and Stroke
Goswami, A., Sen, P., Jana, K., & Raha, S. (2013) · Springer eBooks · doi:10.1007/978-1-4614-9099-9_3 · Cited by 1
Shin, Y.-K., Choi, J.-W., Oh, S., & Chung, J. (2015) · Journal of Nutrition and Health · doi:10.4163/jnh.2015.48.6.468 · Cited by 1
Pak, M. E., & Choi, B. T. (2016) · Journal of Life Science · doi:10.5352/jls.2016.26.12.1458 · Cited by 1
Mitochondrial dynamics in neurodegenerative diseases
Alarcón‐Aguilar, A., Maycotte, P., Cortés-Hernández, P., López‐Díazguerrero, N. E., & Königsberg, M. (2019) · Gaceta Médica de México · doi:10.24875/gmm.m19000270 · Cited by 1
Micronutrients and Parkinson’s Disease
Azmin, S., Rani, R. M., & Ibrahim, N. M. (2022) · Nutritional neurosciences · doi:10.1007/978-981-16-6467-0_9 · Cited by 1
Modulation of the ROCK pathway in models of Parkinson´s disease
Saal, K. A. (2015) · doi:10.53846/goediss-5423 · Cited by 1
Investigating Tau pathology in an in vitro model for Alzheimer’s disease
Powrie, Y. S. L. (2016) · SUNScholar (Stellenbosch University) · Cited by 1
Detection of Mitochondrial Toxicity Using Zebrafish
Chan, S. S. L., & Williamson, T. (2018) · Wiley eBooks · doi:10.1002/9781119329725.ch21 · Cited by 1
Haddadi, N. (2019) · OPUS - Open Publications of UTS Scholars (University of Technology Sydney) · Cited by 1
Ibrakaw, A. S., Omoruyi, S. I., Ekpo, O. E., & Hussein, A. A. (2020) · Preprints.org · doi:10.20944/preprints202008.0054.v1 · Cited by 1
Lipton, S. A. (2017) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.725601011.793538932 · Cited by 1
Weller, S. R., Burnell, J. E., Aho, B. M., Obeng, B., Ledue, E. L., Shim, J. K., Hess, S. T., & Gosse, J. A. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.09.27.509813 · Cited by 1
Neuroprotective Effects of Photobiomodulation and Taurine on SH-SY5Y CellsPreprint
Rossato, R. C., Albuquerque, A. L., Salles, G. N., Porcionatto, M. A., Granato, A. E. C., Ulrich, H., dos Santos, M. I. B., & Soares, C. P. (2024) · Preprints.org · doi:10.20944/preprints202404.0362.v1 · Cited by 1
Microglia demostrate age-dependent performance and interaction with beta-amyloid peptide
Lidónio, G. M. D. C., Brites, D. M. T. O., & Dias, D. M. A. (2013) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT)
Drp1 ablation in the adult mouse forebrain
Oettinghaus, B. (2014) · edoc (University of Basel) · doi:10.5451/unibas-006288258
Proteomics of mouse cortex following conditional deletion of Psmc1 proteasomal subunit in neurones
Elkharaz, J. (2013) · Nottingham ePrints (University of Nottingham)
Parkinson’s Disease: New Insights
Ivana Scovassi, A. (2013) · Biochemistry & Pharmacology Open Access · doi:10.4172/2167-0501.1000e146
Neuroprotective Properties of Partridgeberry (Vaccinium vitis-idaea L. var. minus Lodd) Polyphenols
Bhullar, K. S. (2014) · DalSpace (Dalhousie University)
Drp1 ablation in the adult mouse forebrain
Fakultät, P.-N. (2014)
da Silva, C. M. (2015) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.5.2015.tde-09062015-144939
Mass Spectrometry-Based Investigation of APP-Dependent Mechanisms in Neurodegeneration
Chaput, D. (2015) · Digital Commons - University of South Florida (University of South Florida)
Antioxidant Activity of Ascorbic Acid Analogs Containing a Nitrogen Atom in the Ring
Mochizuki, M., Nomura, S., & Inami, K. (2016) · Heterocycles · doi:10.3987/com-16-13410
Ramanan, V. K., & Saykin, A. J. (2013)
Nejatbakhsh, A. (2016) · YorkSpace (York University)
Masoud, S. T. (2017) · TSpace (University of Toronto)
Li, X., Ingram, T. L., Wang, Y., Derecka, K., Courtier, N., Piana, M., Hardy, I. C. W., Chakrabarti, L., & Stöger, R. J. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.09.14.296053
An Investigation of the Relationship between SIRT1 Gene Polymorphisms and Parkinson’s Disease
KUŞÇU, M., DEMİREL, E. A., Ermiş, E., & Çelik, S. (2020) · Anadolu Kliniği Tıp Bilimleri Dergisi · doi:10.21673/anadoluklin.702828
Curcumin loaded drug delivery systems in Parkinson’s disease
Obulesu, M. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-822448-9.00007-8
Yu, L., Shen, R., Guo, Y., Guo, Y., Li, C., Song, Y., & Wang, D. (2021) · Biocell · doi:10.32604/biocell.2021.014602
MaCheng-cheng, W.-W., Zhou, H., YuYuan-di, H.-L., Ding, X., & Xiao, X. (2013)
Lv, X., Qiu, J., Hao, T., Zhang, H., Jiang, H., & Tan, Y. (2021) · Research Square · doi:10.21203/rs.3.rs-526939/v1
Gauvreau, N. L., Bragg, L. M., Dhiyebi, H. A., Servos, M. R., & Craig, P. M. (2022) · SSRN Electronic Journal · doi:10.2139/ssrn.4053548
Lu, Y., Fang, Z., Ji, W., Wu, Y., Shen, Q., Qiu, X., Wang, L., Zhang, D., Liu, Y., Yang, N., et al. (2022) · SSRN Electronic Journal · doi:10.2139/ssrn.4046037
Zhao, H., Li, L., & Ye, Q. (2020) · Research Square · doi:10.21203/rs.3.rs-105138/v1
Oladele, J. O., Oladele, O. T., Adewole, T. S., Oyeleke, O. M., & Oladiji, A. T. (2022) · Advances in medical diagnosis, treatment, and care (AMDTC) book series · doi:10.4018/978-1-6684-5129-8.ch010 · Cited by 1
Ma, C. J. (2022) · Korean Journal of Medicinal Crop Science · doi:10.7783/kjmcs.2022.30.4.278
TNFR2-NIK-cAbl axis for neurodegenerationPreprint
Erol, A. (2023) · doi:10.31219/osf.io/xg6hw
Zhou, Q., Xu, M., Liu, B., Han, X., Ma, Z., Xia, T., & Gu, X. (2023) · Research Square · doi:10.21203/rs.3.rs-3506360/v1
Binda, N. S., da Silva, J. F., Matosinhos, R. C., & Gomez, M. V. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-23763-8.00020-8
Advancement in herbal drugs for the treatment of Parkinson’s disease
Shokeen, A., Dhawan, B., Sarwat, M., & Gupta, S. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-13587-3.00016-3
Single-molecule Mapping of Amyloid-β Oligomer Insertion into Lipid BilayersPreprint
Dey, A., Patil, A., Arumugam, S., & Maiti, S. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.02.21.581487
Additional file 2 of Identification of potential biomarkers for pathogenesis of Alzheimer’s disease
Wang, H., Han, X., & Gao, S. (2021) · Figshare · doi:10.6084/m9.figshare.14913752
Additional file 3 of Identification of potential biomarkers for pathogenesis of Alzheimer’s disease
Wang, H., Han, X., & Gao, S. (2021) · Figshare · doi:10.6084/m9.figshare.14913755
Metabolite-Associated Disease Conditions
Chen, C. (2024) · Springer eBooks · doi:10.1007/978-3-031-55287-8_17
Nutraceuticals in the prevention and treatment of Alzheimer's disease
Mishra, D. K., Mishra, S. K., Asthana, A., Audah, K. A., Singh, M. P., & Singh, S. K. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-15540-6.00008-2
Deep brain stimulation using animal models of Parkinson's disease
El-Feky, A. S., Ali, F. M., Abbas, F. M., & Mohamed, H. H. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-16128-5.00009-8
Sahu, G., Satpathy, S., Vyas, K., radki, A., dewangan, M., Patel, V. J., Roy, A., & Ajazuddin, M. (2025) · Nanoscience & Nanotechnology-Asia · doi:10.2174/0122106812340671250108064331 · Cited by 2
Expression Pattern of the AB1-Gal4 Driver in Drosophila Third-Instar Larvae
Ogienko, A. A., Andreyeva, E. N., Yarinich, L. A., Pindyurin, A. V., Battulina, N. V., & Omelina, E. S. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26093923
Succinate Dehydrogenase in Mitochondrial Disorders
Tripathi, S., Sharma, Y., & Kumar, D. (2025) · Springer eBooks · doi:10.1007/978-981-96-6831-1_5
Ozone-induced Neurotoxicity: Mechanistic Insights and Implications for Neurodegenerative Diseases
Bjørklund, G., Gurgas, L., & Hangan, T. (2025) · Current Medicinal Chemistry · doi:10.2174/0109298673375058250624070823
Shi, Z., Yu, Z., Gu, L.-H., Ma, Z., Chen, Q.-B., Wen, L.-B., Waddington, J. L., & Zhen, X.-C. (2025) · Acta Pharmacologica Sinica · doi:10.1038/s41401-025-01641-4
Franco, F. N., Cardoso, L. D. C., Silva, B. N. M., de Araújo, G. R., & Chaves, M. M. (2025) · Biochemistry and Biophysics Reports · doi:10.1016/j.bbrep.2025.102291
Sun, M., Yu, L., Bai, L., Liu, X., Xiong, Y., Zhao, X., Zhong, X., Ran, M., Wang, Y., Yan, X., et al. (2025) · Chinese Chemical Letters · doi:10.1016/j.cclet.2025.111948
Bordet, S. (2025) · International review of movement disorders · doi:10.1016/bs.irmvd.2025.09.004
Abueva, C. D. G. (2025) · Korean Intraoperative Neuromonitoring Society · doi:10.54441/jnn.2025.5.2.61
Metadata
- Authors
- Yan, M. H., Wang, X., & Zhu, X.
- Affiliations
- Case Western Reserve University (US)
- Corresponding author
- Wang, Xinglong
- Zhu, Xiongwei
- Venue
- Free Radical Biology and Medicine
- Publisher
- Elsevier BV
- Published
- 2013-09
- Volume
- 62
- Pages
- 90-101
- ISSN
- 0891-5849 (ISSN-L)
- PMC
- PMC3744189
- OpenAlex
- W2027783468
- Cited by
- 718
- References
- 209
- Citations by year
- 2026: 14 · 2025: 34 · 2024: 73 · 2023: 56 · 2022: 69 · 2021: 67 · 2020: 53 · 2019: 47 · 2018: 53 · 2017: 71 · 2016: 54 · 2015: 49 · 2014: 48 · 2013: 30
- FWCI
- 16.31
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Free Radical Biology and Medicine (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- the National Institutes of Health (AG031852, NS071184)
- Alzheimer's Association (IIRG-10–173358)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mitochondrial Function and Pathology
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
- Keywords
- Alzheimer's disease, Parkinson's disease, mitochondrial dysfunction, oxidative stress, mitochondrial DNA, mitochondrial dynamics, reactive oxygen species, neurodegeneration, mitochondrial homeostasis
- MeSH terms
- Alzheimer Disease, Humans, Mitochondria, Nerve Degeneration, Neurons, Parkinson Disease, Amyloid beta-Peptides, Cell Death, Reactive Oxygen Species, Oxidative Stress
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review